Optomed Plc: Interim report, January – September 2022
Optomed Plc Stock Exchange Release 3 November 2022 at 9.00, Helsinki Optomed Plc: Interim report, January – September 2022 July – September 2022 · Revenue increased by 10.7 percent to EUR 3.7 (3.3) million. · Devices segment revenue increased by 45.4 percent to EUR 1.7 (1.2) million. The growth rate of the segment was 40.2% at comparable exchange rates. · In the Devices segment all sales channels but China came out with a solid performance. · Software segment revenue decreased by 7.9 percent to EUR 2.0 (2.2) million due to the segment focusing more on R&D. ·